Sort
326,823 grants matching “clinical trial”
New Approaches to Dementia Heterogeneity
$3,158,395Bruce L Miller · University Of California, San Francisco · P30 · FY2020 · AG
Aging Intervention Studies
$3,157,503Julie Mattison · National Institute On Aging · ZIA · FY2025 · AG
Suicide Care Research Center
$3,157,410Katherine Anne Comtois · University Of Washington · P50 · FY2025 · MH
Prostate Cancer Imaging
$3,157,187Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
TERRY BEIRN COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON
$3,157,100University Of Minnesota Twin Cities · U01 · FY2005 · AI
A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
$3,156,733Steven Lee Wagner · University Of California, San Diego · R01 · FY2021 · AG
The Four Repeat Tauopathy Neuroimaging Initiative
$3,156,502Adam L Boxer · University Of California, San Francisco · R01 · FY2018 · AG
NIAID VIROLOGY QUALITY ASSURANCE (VQA)
$3,156,300Thomas Denny · Duke University · N01 · FY2019 · AI
Biological and mechanical therapies enabled by cardiovascular interventional MRI
$3,155,649Robert J Lederman · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine
$3,155,270Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · HL
Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)
$3,155,199David A Smelson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · MH
The Four Repeat Tauopathy Neuroimaging Initiative
$3,154,975Adam L Boxer · University Of California, San Francisco · R01 · FY2019 · AG
Genetics of Early Onset Parkinson's Disease: Mitochondrial Drivers of PD Pathogenesis
$3,154,937Derek Narendra · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Johns Hopkins Alzheimer's Disease Research Center
$3,154,067Marilyn S Albert · Johns Hopkins University · P30 · FY2020 · AG
Upstream pathogenesis in familial and sporadic frontotemporal dementia and motor neuron disease
$3,153,019William W Seeley · University Of California, San Francisco · RF1 · FY2025 · NS
Deciphering the efficacy of posttransplant cyclophosphamide in BMT
$3,152,925Christopher Kanakry · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
UNC Center for AIDS Research
$3,152,617Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2014 · AI
KY IDeA Networks of Biomedical Research Excellence
$3,152,575Nigel G Cooper · University Of Louisville · P20 · FY2009 · RR
Biomarker Signature to Predict the Persistence of Post-Traumatic Headache
$3,152,333Catherine Daniela Chong · Mayo Clinic Arizona · R61 · FY2019 · NS
Development of vaccines to bacterial diseases found especially in children
$3,151,084John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Johns Hopkins University Kampala-Nanning Clinical Trial Unit
$3,150,635Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2014 · AI
StATins Use in intRacerebral hemorrhage patieNts (SATURN)
$3,150,398Magdy H Selim · Beth Israel Deaconess Medical Center · U01 · FY2022 · NS
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$3,150,358Pamela B Davis · Case Western Reserve University · UL1 · FY2008 · RR
University of Buffalo Clinical and Translational Science Institute
$3,150,244Timothy F Murphy · State University Of New York At Buffalo · UL1 · FY2024 · TR
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine
$3,150,138Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI